Treatment of Gout
- 2 December 1971
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 285 (23) , 1303-1306
- https://doi.org/10.1056/nejm197112022852306
Abstract
GOUT is a consequence of hyperuricemia. It is of interest that our generally accepted upper limit of normal for serum unite, a concentration greater than 7 mg per 100 ml, corresponds closely to the solubility of sodium urate in human plasma at pH 7.4. Concentrations higher than this represent a supersaturated solution, a system in which the "excess" urate will, under appropriate circumstances, precipitate. Resultant urate deposition occurs in a variety of tissues, including synovium, cartilage, tendon, subchondral bone and renal parenchyma. The almost universal association of microcrystalline monosodium urate in acute gouty synovial effusions implies that inflammatory arthritis, the . . .Keywords
This publication has 3 references indexed in Scilit:
- Depletion of Erythrocyte Phosphoribosylpyrophosphate in ManNew England Journal of Medicine, 1970
- Colchicine: a common mechanism for its anti‐inflammatory and anti‐mitotic effectsArthritis & Rheumatism, 1968
- Effect of allopurinol (4-Hydroxypyrazolo-(3,4-d)pyrimidine) on serum and urinary uric acid in primary and secondary goutThe American Journal of Medicine, 1964